Femasys Inc. (NASDAQ:FEMY) Sees Significant Drop in Short Interest

Femasys Inc. (NASDAQ:FEMYGet Free Report) saw a significant decrease in short interest in January. As of January 15th, there was short interest totalling 495,600 shares, a decrease of 5.5% from the December 31st total of 524,500 shares. Based on an average trading volume of 857,100 shares, the days-to-cover ratio is presently 0.6 days. Approximately 2.5% of the company’s shares are short sold.

Analysts Set New Price Targets

Separately, HC Wainwright cut their price objective on Femasys from $13.00 to $10.00 and set a “buy” rating on the stock in a report on Tuesday, November 14th.

View Our Latest Research Report on FEMY

Femasys Trading Up 6.9 %

Shares of NASDAQ:FEMY opened at $0.80 on Friday. The firm has a market cap of $17.32 million, a price-to-earnings ratio of -0.82 and a beta of -3.67. The company has a quick ratio of 4.40, a current ratio of 4.68 and a debt-to-equity ratio of 0.01. Femasys has a 12 month low of $0.25 and a 12 month high of $4.75. The company’s fifty day simple moving average is $0.91 and its 200 day simple moving average is $0.90.

Femasys (NASDAQ:FEMYGet Free Report) last released its quarterly earnings results on Tuesday, November 14th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.01). The firm had revenue of $0.24 million during the quarter, compared to analyst estimates of $0.40 million. Femasys had a negative net margin of 1,164.78% and a negative return on equity of 100.01%. As a group, research analysts forecast that Femasys will post -0.93 EPS for the current fiscal year.

Institutional Investors Weigh In On Femasys

Several institutional investors have recently bought and sold shares of FEMY. Vanguard Personalized Indexing Management LLC bought a new position in shares of Femasys during the 3rd quarter worth approximately $35,000. Cetera Advisor Networks LLC bought a new position in Femasys in the first quarter valued at $27,000. Virtu Financial LLC acquired a new stake in Femasys in the 2nd quarter valued at $39,000. LPL Financial LLC acquired a new stake in Femasys in the 2nd quarter valued at $51,000. Finally, Wealthspire Advisors LLC bought a new stake in Femasys during the 3rd quarter worth about $84,000. Institutional investors own 8.29% of the company’s stock.

Femasys Company Profile

(Get Free Report)

Femasys Inc, a biomedical company, develops novel solutions for women's healthcare market in the United States and internationally. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination.

See Also

Receive News & Ratings for Femasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Femasys and related companies with MarketBeat.com's FREE daily email newsletter.